Suppr超能文献

基于 2016 年修订版世界卫生组织分类的 [C]蛋氨酸正电子发射断层扫描在新诊断和未经治疗的脑胶质瘤中的诊断性能。

Diagnostic Performance of [C]Methionine Positron Emission Tomography in Newly Diagnosed and Untreated Glioma Based on the Revised World Health Organization 2016 Classification.

机构信息

Department of Neurosurgery, Osaka City University Graduate School of Medicine, Osaka, Japan.

Department of Neurosurgery, Osaka City University Graduate School of Medicine, Osaka, Japan.

出版信息

World Neurosurg. 2021 Apr;148:e471-e481. doi: 10.1016/j.wneu.2021.01.012. Epub 2021 Jan 11.

Abstract

BACKGROUND

The relationship between uptake of amino acid tracer with positron emission tomography (PET) and glioma subtypes/gene status is still unclear.

OBJECTIVE

To assess the relationship between uptake of [C]methionine using PET and pathology, IDH (isocitrate dehydrogenase) mutation, 1p/19q codeletion, and TERT (telomerase reverse transcriptase) promoter status in gliomas.

METHODS

The participants were 68 patients with newly diagnosed and untreated glioma who underwent surgical excision and preoperative [C]methionine PET examination at Osaka City University Hospital between July 2011 and March 2018. Clinical and imaging studies were reviewed retrospectively based on the medical records at our institution.

RESULTS

The mean lesion/contralateral normal brain tissue (L/N) ratio of diffuse astrocytomas was significantly lower than that of anaplastic astrocytomas (P = 0.00155), glioblastoma (P < 0.001), and oligodendrogliomas (P = 0.0157). The mean L/N ratio of IDH mutant gliomas was significantly lower than that of IDH wild-type gliomas (median 1.75 vs. 2.61; P = 0.00162). A mean L/N ratio of 2.05 provided the best sensitivity and specificity for distinguishing between IDH mutant and IDH wild-type gliomas (69.2% and 76.2%, respectively). The mean L/N ratio of TERT promoter mutant gliomas was significantly higher than that of TERT promoter wild-type gliomas (P = 0.0147). Multiple regression analysis showed that pathologic diagnosis was the only influential factor on L/N ratio.

CONCLUSIONS

Distinguishing glioma subtypes based on the revised 2016 World Health Organization classification of the central nervous system tumors on the basis of [C]methionine PET alone seems to be difficult. However, [C]methionine PET might be useful for predicting the IDH mutation status in newly diagnosed and untreated gliomas noninvasively before tumor resection.

摘要

背景

正电子发射断层扫描(PET)中氨基酸示踪剂摄取与胶质瘤亚型/基因状态之间的关系仍不清楚。

目的

评估 [C]蛋氨酸 PET 摄取与胶质瘤的病理学、异柠檬酸脱氢酶(IDH)突变、1p/19q 缺失和端粒酶逆转录酶(TERT)启动子状态之间的关系。

方法

2011 年 7 月至 2018 年 3 月,大阪城市大学医院对 68 例新诊断和未经治疗的脑胶质瘤患者进行了手术切除和术前 [C]蛋氨酸 PET 检查。回顾性地根据我院的病历对临床和影像学研究进行了综述。

结果

弥漫性星形细胞瘤的病灶/对侧正常脑组织(L/N)比值的平均值明显低于间变性星形细胞瘤(P = 0.00155)、胶质母细胞瘤(P < 0.001)和少突胶质细胞瘤(P = 0.0157)。IDH 突变型胶质瘤的平均 L/N 比值明显低于 IDH 野生型胶质瘤(中位数 1.75 比 2.61;P = 0.00162)。2.05 的平均 L/N 比值可最佳地区分 IDH 突变型和 IDH 野生型胶质瘤(分别为 69.2%和 76.2%)。TERT 启动子突变型胶质瘤的平均 L/N 比值明显高于 TERT 启动子野生型胶质瘤(P = 0.0147)。多元回归分析显示,病理诊断是唯一影响 L/N 比值的因素。

结论

根据 2016 年修订的中枢神经系统肿瘤世界卫生组织分类,单凭 [C]蛋氨酸 PET 对胶质瘤亚型进行鉴别似乎较为困难。然而,[C]蛋氨酸 PET 可能有助于在肿瘤切除前对新诊断和未经治疗的胶质瘤进行非侵入性预测 IDH 突变状态。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验